Poly Medicure Limited — Updates, 06-05-2025: Press Release

Poly Medicure Limited has announced a board meeting on the financial results for the quarter and half-year. Consolidated revenue rose 17% in Q4 and 21% for FY25, driven by a 24% jump in exports despite geopolitical headwinds. Domestic revenue grew 24%, mainly due to a 69% surge in the renal division. EBITDA increased 24%, with margins expanding 160 bps to 27%. PAT grew 34% alongside a 270 bps margin rise. The company invested Rs 325 Cr in CAPEX to boost manufacturing capacity and support growth.